• En
  • Fr
Expert de la donnée de santé – Activité CRO Clinique Expert de la donnée de santé – Activité CRO Clinique Expert de la donnée de santé – Activité CRO Clinique Expert de la donnée de santé – Activité CRO Clinique
  • En
  • Fr

Cardiology (Coronary artery disease, hypertension,..)

Accueil » Cardiology (Coronary artery disease, hypertension,..)
Cardiology (Coronary artery disease, hypertension,..) Pulmonology Rare diseases (PAH, sclerodermia, Gaucher's disease)
112 – Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension.
8 May 2020

Initial combination therapy plays a central role in managing pulmonary arterial hypertension (PAH) [1–4]. Patients with low- or intermediate-risk of 1-year mortality at diagnosis should be

Read more
Cardiology (Coronary artery disease, hypertension,..)
68 – Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
28 December 2012

To determine how cardiologists manage medical treatment in HF patients after hospital discharge, according to LVEF…

Read more
Cardiology (Coronary artery disease, hypertension,..)
49 – [Multifactorial and typological analysis of frailty in uncontrolled hypertensives. The Eclat survey].
21 April 2009

The aim of the Eclat survey was to evaluate the frequency of frailty in uncontrolled hypertensives and to individualize different frailty profiles…

Read more
Cardiology (Coronary artery disease, hypertension,..)
46 – Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: The Impact-Reco Programme.
1 January 2009

The aim of the Impact-Reco programme was to analyse prescription rates of CHF drugs in stable outpatients with CHF related to left ventricular (LV)…

Read more
Cardiology (Coronary artery disease, hypertension,..)
45 – Masked hypertension: a systematic review.
1 September 2008

The purpose of this research was to review the literature on masked hypertension. Studies, reviews and editorials on masked hypertension were identified…

Read more
Cardiology (Coronary artery disease, hypertension,..)
44 – Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.
16 November 2007

To determine prescription rates of CHF drugs, and to assess predictive factors for drug prescription using data from a large panel of French…

Read more
Cardiology (Coronary artery disease, hypertension,..)
41 – [First-intent monotherapy: persistence rate of antihypertensive treatment is better with angiotensin receptor blockers. Ol’métrise Cardio survey results].
1 July 2007

To describe, according to the type of first-line antihypertensive monotherapy (FLAM) the persistence rate and the cumulative probability of its potential…

Read more
Cardiology (Coronary artery disease, hypertension,..)
38 – Predictive factors for masked hypertension within a population of controlled hypertensives.
1 December 2006

The aim of this work is to better define the clinical profile of masked hypertensives within a population with controlled office blood pressure (BP) and…

Read more
Cardiology (Coronary artery disease, hypertension,..)
37 – [Prevalence and mechanism of masked hypertension: the ol’mesures survey].
31 July 2006

To evaluate the prevalence and reproducibility of MH after excluding confusing factors [method and time of blood pressure (BP) measurement, …

Read more
Cardiology (Coronary artery disease, hypertension,..)
35 – [Combination therapy at hospital discharge in the USIC 2000 survey].
30 December 2005

We tried to determine the prognostic impact of triple (antiplatelet agents, statins and beta-blockers) and quadruple (the same+ACE inhibitors)…

Read more
Load More
  • HOME
  • OUR NEWS
  • OUR SPECIALIZATIONS
  • OUR SERVICES
  • CASE STUDIES
  • OUR REFERENCES
  • OUR PUBLICATIONS
  • CONTACT

Suscribe to our newsletter

By clicking on the link below, you will be redirected to Youtube. Third-party cookies may then be installed on your browser. These cookies are not implemented directly by the Soladis Clinical Studies site but by the site to which you connect.
Important: these cookies are subject to their own privacy policies and are in no way the responsibility of Soladis.
You can view Youtube's cookie policy by clicking on the following link: Google – Privacy & terms

  Follow Soladis on Youtube

By clicking on the link below, you will be redirected to LinkedIn. Third-party cookies may then be installed on your browser. These cookies are not implemented directly by the Soladis Clinical Studies site but by the social network site to which you connect.
These cookies are subject to their own privacy policies and are in no way the responsibility of Soladis.
You can view LinkedIn's cookie policy by clicking on the following link :  LinkedIn – Cookie Policy

Follow Soladis on LinkedIn

En cliquant sur le lien ci-dessous, vous allez être redirigé vers Youtube. Des cookies tiers peuvent alors être installés sur votre navigateur. Ces cookies ne sont pas implémentés directement par le site Soladis Clinical Studies mais par le site auquel vous vous connectez.
Important : ces cookies sont soumis à leurs propres politiques de confidentialité et ne relèvent en aucun cas de la responsabilité de Soladis.
Vous pouvez consulter la politique de Youtube en matière de cookies en cliquant sur le lien suivant : Google – Règles de confidentialité et conditions d’utilisation

  Suivre Soladis sur Youtube

En cliquant sur le lien ci-dessous, vous allez être redirigé vers LinkedIn. Des cookies tiers peuvent alors être installés sur votre navigateur. Ces cookies ne sont pas implémentés directement par le site Soladis Clinical Studies mais par le site de réseau social auquel vous vous connectez.
Ces cookies sont soumis à leurs propres politiques de confidentialité et ne relèvent en aucun cas de la responsabilité de Soladis.
Vous pouvez consulter la politique de LinkedIn en matière de cookies en cliquant sur le lien suivant : LinkedIn – Politique relative aux cookies

  Suivre Soladis sur LinkedIn